## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 




## 

## 

## 

## 

## 

## 

## 



## 

## 

||||||Unrestricted|Funds|EndowmentFunds|Total Funds|
|---|---|---|---|---|---|---|---|---|
||||||Period 15.07.2021 to||Period 15.07.2021|Period 15.07.2021|
||||||31.12.2022||to31.12.2022|to31.12.2022|
|||||Note||8|6|6|
|Income and endowments|||||||||
|from:|||||||||
|Gift ofexpendable|endowment||||||3,017,619|3,017,619|
|Investment<br>income||||||52,957||52,957|
|Other||||||206||206|
|Total income||||||53,163|3,017,619|3,070,782|
|Expenditure on:|||||||||
|Cost ofraising funds||||3|||35,320|35,320|
|Charitable<br>activities||||4,5||||82,904|
|Total expenditure||||||82,904|35,320|118,224|
|Net income/(expenditure)|||before||||||
|investment<br>gains/(losses)||||||(29„741)|2,982,299|2,952,558|
|Net gain/(losses)|on Investments||||||||
|Realised gains/(losses)||on|||||||
|investments|||||||(28,573)|(28,573)|
|Unrealised<br>gains/posses)|||||||||
|on investments|||||||(247,205)|(247,205)|
|Net income/(expenditure)||||||(29,741)|2,706,521|2,676,780|
|Transfers between|funds|||10||29,741|(29,741)||
|Net movement<br>in|funds||||||2,676,780|2,676,780|
|Balance carried forward|||||||||
|at 31 December 2022|||||||2,676,780|2,676,780|





## 




## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

||||Unrestricted|Endowment|Total|
|---|---|---|---|---|---|
||||Fund|Fund|Funds|
||||31.12.2022|31.12.2022|31.12.2022|
||||6|E|E|
|UK equities|||17,376||17,376|
|UK fixed interest securities|||4,770||4,770|
|UK alternatives|||6,987||6,987|
|Overseas equities|||19,094||19,094|
|Overseas fixed interest securities|||1,516||1,516|
|Interest on|cash deposits||3,214||3,214|
||||52,957||52,957|
|3.<br>Cost ofraising funds||||||
||||Unrestricted|Endowment|Total|
||||Fund|Fund|Funds|
||||31.122022|31.12.2022|31.12.2022|
||||E|E|E|
|Investment|management|costs||20,175|20,175|
|Financial advisor fees||||15,145|15,145|
|||||35,320|35,320|
||||Unrestricted|Endowment|Total|
||||Fund|Fund|Funds|
||||31.12.2022|31.12.2022|31.12.2022|
||||E|E|E|
|University<br>scholarships|||72,000||72,000|
||||72,000||72,000|





## 

|December 2022||||||||
|---|---|---|---|---|---|---|---|
|Expenditure|on charitable|||activities||||
||||||Unrestricted|Endowment|Total|
||||||Fund|Fund|Funds|
||||||31.122022f|31.12.2022<br>6|31.12.2022<br>6|
|Grants (Note 4)|||||72,000||72,000|
|Admin and accountancy|||||8,250||8,250|
|Bank charges|||||30||30|
|Independent<br>Examiner|||||2,160||2,160|
|Oflice expense|||||464||464|
||||||82,904||82,904|
|6.<br>Fixed assets|investments|||||||
||||||31.12.2022|||
||||||6|||
|Quoted investment||||||||
|Market value at15 July 2021||||||||
|Additions|||||3,122,547|||
|Disposals at opening|market||value||(214,849)|||
|Net unrealised<br>gain/goss)||in the period|||(247,205)|||
|Market value at31December 2022|||||2,669393|||
|Historical costat31December 2022|||||2,907,698|||
|Investments<br>atmarket||value|||||Total|
||||||UK|Overseas|31.122022|
||||||6|6|6|
|Equities|||||723,006|1,179,377|1,902,383|
|Fixed interest securities|||||159,769|48,480|208,249|
|Alternatives|||||413,773||413,773|
|Cash held within investment|||portfolio||136,088||136,088|
|Total|||||1.432,635|1,227,857|2,660+93|
|Material investments||||||||
||||||31.12.2022|||
||||||6|||
|Treasury 7/8% Green Gilt|||||52,521|||
|Astrazeneca<br>Pic|||||61,699|||
|Shell Pic|||||74,432|||
|Ishares VII Pic|||||83,250|||
|Baillie Gifford Jpn Tst|||||68,490|||
|Man Fund Mgmt (UK)|||||50,860|||
|JPMorgan Emerg Mkts||Inv|Tst||71110|||





## 


|mber 20|22||||||
|---|---|---|---|---|---|---|
|Liabilities||||||31.12.2022|
|||||||6|
|Amounts|falling|due|within|one|year:||
|Accruals||||||17,611|



## 

## 

## 


## 

## 




## 

||Unrestricted|Endowment||
|---|---|---|---|
||Funds|Funds|Total|
||31.12.2022|31.12.2022|31.12.2022|
|Assets||2,694,391|2,694,391|
|Liabilities||(17,611)|(17,611)|
|||2,676,780|2,676,780|